Quinethazone; reserpine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for quinethazone; reserpine and what is the scope of patent protection?
Quinethazone; reserpine
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for quinethazone; reserpine
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | quinethazone; reserpine at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for quinethazone; reserpine
US Patents and Regulatory Information for quinethazone; reserpine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lederle | HYDROMOX R | quinethazone; reserpine | TABLET;ORAL | 013927-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
